Search

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.

… Tuesday, March 31, 2026 Mesothelioma , a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men — especially those who may have been exposed to asbestos while working in manufacturing or construction. About 3,300 people are diagnosed

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.

… Monday, June 30, 2025 For people with  prostate cancer  considered “intermediate risk” —  small tumors confined to one area of the prostate – doctors are increasingly using a treatment known as  focal therapy  (partial gland ablation). One approach uses an advanced and highly precise energy source known

Research by a team at Memorial Sloan Kettering Cancer Center has found important new insights into colorectal cancer in Nigeria that have significant implications for treating the disease in West Africa. This research also expands awareness of how different population groups may require different approaches in the diagnosis and treatment of cancer.

… Wednesday, November 24, 2021 Colorectal cancer is common — and deadly — around the world.   But too often, major population groups are not represented in colorectal cancer research, which focuses mainly on patients in America and Western Europe.   A team of researchers from Memorial Sloan Kettering Cancer

The Patient and Family Advisory Council for Quality (PFACQ) marks five years of ensuring the patient and family perspective is included in everything MSK does.

… Wednesday, January 1, 2020 In 2014, Kate Niehaus, a former patient active in volunteer work for Memorial Sloan Kettering, was approached by Kent Sepkowitz, an infectious disease specialist and Deputy Physician-in-Chief for Quality and Safety, with a proposal to make MSK’s outstanding cancer care even

Based on a clinical trial led by an MSK investigator, the FDA has approved revumenib (Revuforj®) for patients 1-year-old and older who have leukemia that has come back after treatment and whose cancer carries molecular changes called NPM1 mutations and KMT2A translocations.

… Wednesday, October 29, 2025 On October 24, 2025, the U.S. Food and Drug Administration (FDA)  approved revumenib (Revuforj ® ) for patients 1-year-old and older who have leukemia that has come back after treatment and whose cancer carries a molecular change called an NPM1 mutation. In November 2024,

Mutations that drive cancer growth also make a cell more noticeable to the immune system.

… Wednesday, May 11, 2022 Many cancers contain similar genetic “hotspots” — areas of DNA that are likely to be mutated. For example, more than 50% of cancers contain a mutation in a gene called TP53 , often within a narrow DNA range. Researchers know that hotspots can contribute to cancer development and

A new report says that ovarian cancer research is improving, but more needs to be done, especially with regards to screening at an early stage. Also, where patients receive care makes a big difference in their outcome.

… Friday, March 4, 2016 Summary A new report from the Institutes of Medicine says that ovarian cancer research is improving, but more needs to be done, especially with regards to screening for signs of ovarian cancer  at an early stage. The report also points out that where patients receive care makes

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.

… Thursday, November 11, 2021 The recent accelerated approval of sotorasib (Lumakras TM ) was considered significant because the drug obstructs a cancer-causing protein that for decades scientists thought was “undruggable.” Sotorasib received accelerated approved from the US Food and Drug Administration

As a financial services specialist at MSK, Charlene Jerome helps patients overcome financial barriers to treatment by hunting for free drugs, deep discounts, and financial aid so patients can focus on healing.

… Friday, June 6, 2025 Charlene Jerome, a specialist in patient financial services, is a superhero in the eyes of one of the many patients she’s helped. So much so that patient Melissa Thompson sings her praises. Literally.   Melissa surprised Charlene with an original rap song she titled “Queen Charlene

The award recognizes his lifetime contributions to the field of life sciences, especially related to the training of Chinese scientists who have returned to faculty positions in China.

… Wednesday, October 30, 2019 Dinshaw Patel , who holds the Abby Rockefeller Mauzé Chair in Experimental Therapeutics and is a Member of the Structural Biology Program at MSK, is the recipient of the inaugural C.C. Tan Life Science International Collaboration Award. He was chosen in recognition of his